Researchers have quickly jumped on the small nerve fiber neuropathy (SFN) finding in Fibromyalgia. After starting out with smaller studies some bigger ones are starting to show up, and the outlines of SFN prevalence in FM are beginning to emerge.
This Greek study was not particularly big – Read more [...]
The Montoya Effect
Jose Montoya’s enthusiasm and sense of urgency is clearly catching on at Stanford. You don’t often see sentences like the one below in the first part of the latest Stanford study on ME/CFS:
“The high prevalence … in the United States, combined with profound disability Read more [...]
“If we lose sight of pleasures ... that intoxicate the senses in the most sensuous and beautiful and simplest of ways, then we've lost a lot." - Savannah Page
Researchers have used heat, electricity, chemicals, and pressure to evoke pain in FM patients and controls, and in every study people with Read more [...]
The Other Davis
The ME/CFS community got some tough news recently with the AHRQ report finding fault with most ME/CFS diagnostic and treatment trials. We had some good news, too, when we saw a top immune researcher at a top lab, Derya Unutmaz, applying cutting edge technology to ME/CFS patients. Now Read more [...]
Solve ME/CFS took its shot at the AHRQ report and it didn't pull any punches. The Solve ME/CFS review is notable because it was produced by an experienced researcher, Suzanne Vernon PhD, in collaboration with a Research Advisory Board that is made up of doctors, researchers, and industry leaders.
(In Read more [...]
Dr. Derya Unutmaz is one of those researchers we want in the ME/CFS field; he’s well-published, he’s an ace in immune system functioning, he has his own laboratory, and he’s doing cutting edge work. Suzanne Vernon described meeting in San Francisco with Esther Dyson, a technology Read more [...]
Engineering Better Health With Low Dose Naltrexone
One Size Fits All Approach Fading
“ We envision that the concepts presented in this paper will lead to novel individualized treatments where treatment dosages can be assigned by a mobile device at the disposal of the participant.”
Dr. Jarred Read more [...]
My assumption has been that the AHRQ knows what it’s doing and is doing its job well. That assumption is based on the fact that the AHRQ appears to be thriving as an institution.
The AHRQ notes in its report, however, that “divergent and conflicted opinions are common” even among experts Read more [...]